Why the bargain the GOP and President Trump may be unraveling and more questions about Trump family business entanglements here and abroad
Guest Host: Steve Roberts
A new study suggests antidepressants may be no more effective than placebo in all but severe cases of depression. A look at how drug effectiveness is measured and weighed against safety concerns in and beyond the drug approval process.
- Blair Johnson Professor of psychology, University of Connecticut; coauthor on new antidepressant study
- Gardiner Harris Science reporter for "The New York Times"
- Dr. Jerry Avorn Professor of Medicine at Harvard Medical School; Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital; author "Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs"
- Dr. William Potter Serves on the FDA's Psychopharmacologic Drugs Advisory Committee, vice president for translational neuroscience at Merck Research Laboratories; board-certified psychiatrist
Most Recent Shows
Reaction to this week's political shocks, why many conservatives are choosing to double down on Trump critics, and then, a conversation on the growing dis-union in America.
Political fallout from the dismissal of FBI director James Comey, how our government created racially segregated cities, and a young Palestinian's perspective on Mideast peace.
Washington Post reporter Dan Balz on covering President Trump and linguist Deborah Tannen on how women support each other with the words they use.